Dear Doctor Letter (Rote-Hand-Brief) on Lariam® (mefloquine): Risk of neuropsychiatric and other serious adverse reactions as well as inclusion of new contraindications
2013.09.10
Active substance: mefloquine
Important information regarding new contraindications (Blackwater fever, severe impairment of liver function) as well as on the risk of neuropsychiatric and other serious adverse reactions under Lariam® (mefloquine) for malaria chemoprophylaxis and as stand-by emergency treatment.
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN